Viewing Protocol Section

Viewing Protocol Section

Thank You for evaluating our software.

Clinical Trials

To give you an idea of how we make custom software. We have taken all of the Clinical Trials Information from our Federal Government(https://clinicaltrials.gov/).

The JSON File Structure of the files is as follows: Full Study -> Study => Sections => Modules. You are currently viewing a Protocol Section and its Modules.

We give the table structure here to give you an idea of what you are looking at. We put the explanation to the left and the data to the right.

A Protocol Section has the following Modules.

1. Identification Module

2. Status Module

3. Sponsor Collaborators Module

4. Oversight Module

5. Description Module

6. Conditions Module

7. Design Module

8. Arms Interventions Module

9. Outcomes Module

10. Eligibility Module

11. Contacts Locations Module

12. References Module

13. IPD Sharing Statement Module

Viewing Protocol Section


Ignite Creation Date: 2024-05-06 @ 6:17 PM
Last Modification Date: 2024-10-26 @ 2:44 PM
Study NCT ID: NCT05602194
Protocol Section: NCT05602194
Start Identification Module Data
Brief Title: Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma
Official Title: A Randomized Trial of Levocarnitine Prophylaxis to Prevent Asparaginase-Associated Hepatotoxicity in Adolescents and Young Adults Receiving Acute Lymphoblastic Leukemia Therapy
Acronym: None
Organization: Childrens Oncology Group
Organization Class: NETWORK
Organization Study ID: ACCL1931
Secondary IDs
Secondary ID Type Domain Link
NCI-2022-08058 REGISTRY None None
ACCL1931 OTHER None None
COG-ACCL1931 OTHER None None
ACCL1931 OTHER None None
U24CA196173 NIH None None
UG1CA189955 NIH CTEP httpsreporternihgovquickSearchUG1CA189955
Start Status Module Data
Status Verified Date: 2024-10
Overall Status: RECRUITING
Study First Submit Date:
Study First Submit QC Date:
Last Update Submit Date:
Status:
Start Sponsor Collaborators Module Data
Investigator:
Lead Sponsor: Childrens Oncology Group
Lead Sponsor Class: NETWORK
Lead Sponsor: Childrens Oncology Group
Start Oversight Module Data
Description Module:
Study Last Update Post Date Type(Status Module):
Attachment: Upload